Corporate News Earnings Snapshot: Johnson & Johnson tops Q3 estimates as Darzalex sales surge; raises FY24 sales outlook by Contributor since / Followers 1 month ago More on Johnson & Johnson: Johnson & Johnson Non-GAAP EPS of $2.42 beats by $0.21, revenue of $22.5B beats by $330M Johnson & Johnson declares $1.24 dividend Johnson & Johnson: You Need To Look At This Chart (Rating Upgrade) Johnson & Johnson: Wait For More Clarity (Rating Downgrade) Texas court rules J&J didn’t skirt bankruptcy rules in talc case: report Tags: JNJ Continue Reading Previous Johnson & Johnson in charts: Innovative Medicine recorded highest sales in Q3Next Bank of America GAAP EPS of $0.81 beats by $0.05, revenue of $25.3B beats by $70M
